Inventor · New York, NY, US

Akiko Koide

19Patents
3h-index
33Co-inventors
60Inventor score

Filing activity: Apr 4, 2002 → Feb 23, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US7556925B2 ανβ3 integrin-binding polypeptide monobodies and their use Chemistry; Metallurgy 66 Expired
US8263350B2 Molecular affinity clamp technology and uses thereof Chemistry; Metallurgy 4 Active
US9512199B2 Fibronectin cradle molecules and libraries thereof Chemistry; Metallurgy 3 Active
US9885050B2 Molecular affinity clamp technology and uses thereof Physics 3 Active
US10519236B2 Antibodies specific to delta 1 chain of T cell receptor Chemistry; Metallurgy 3 Active
US11680091B2 Methods and composition involving thermophilic fibronectin type III (FN3) monobodies Physics 1 Active
US10344091B2 Anti-Galectin-9 antibodies and uses thereof Chemistry; Metallurgy 1 Active
US11492401B2 Therapeutic musk antibodies Chemistry; Metallurgy 0 Active
US11673952B2 Antibodies specific to delta 1 chain of T cell receptor Chemistry; Metallurgy 0 Active
US12391770B2 Compositions and methods comprising antibodies that bind to covalent peptide conjugates Chemistry; Metallurgy 0 Active
US10208110B2 Compositions and methods related to recombinant antibodies to histone posttranslational modifications Physics 0 Active
US10450374B2 Anti-galectin-9 antibodies and uses thereof Chemistry; Metallurgy 0 Active
US12084500B2 Antibodies specific to delta 1 chain of T cell receptor Chemistry; Metallurgy 0 Active
US11414492B2 Anti-galectin-9 antibodies and uses thereof Chemistry; Metallurgy 0 Active
US12312392B2 Methods and composition involving thermophilic fibronectin type III (FN3) monobodies Physics 0 Active
US12049483B2 Selective and noncovalent inhibitors of oncogenic RAS mutants Chemistry; Metallurgy 0 Active
US12162953B2 Enhanced targeting platform Chemistry; Metallurgy 0 Active
US11459400B2 Methods and composition for modifying enzymes Chemistry; Metallurgy 0 Active
US11629191B2 Anti-galectin-9 antibodies and uses thereof Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.